Health Care Equipment & Services

Insider selling in a bullish market: Grewal Harpreet’s routine 186‑share sale of Penumbra Inc. shows prudent portfolio rebalancing, not a bearish signal.

Broadwood Partners’ new stake in STAAR Surgical signals a potential undervaluation, as the firm backs the company’s return to core ophthalmic devices after a failed Alcon merger.

Rothberg’s rule‑based sale of 1.14 M Butterfly Network shares shows investors how a major insider’s disciplined divestment could impact price momentum and future AI‑driven growth potential.

Outset Medical’s insider sell‑to‑cover by EVP Nash Marc shows routine tax liquidity, not a confidence shift, amid a 26 % weekly rally and rising social‑media buzz.

Insider buying shows confidence in Clover Health’s Medicare strategy—Armbrister adds 79,365 shares, backing long‑term growth amid market volatility.

CEO of Kewaunee Scientific Corp. sells 6,854 shares at $37.50 avg; steady insider selling shows normal portfolio management, not panic, and highlights upcoming earnings & capital moves.

Vladimir Galkin’s sudden sale of 643,505 shares of Innovative Eyewear at $1.79 signals deep insider doubts—investors should watch for a possible price correction and changes in ownership stability.

Elevance Health insider sells 24,854 shares tied to RSU vesting in early 2026—tax‑liquidation moves reveal executives’ confidence and offer investors a signal to re‑evaluate risk.

Insider buying by Streamex founder signals quiet confidence in its niche cardiac‑ablation tech—why investors should watch the stock’s upside potential.

Elevance Health insiders sell 6,500+ shares at $1 each amid a $371 stock price—why the moves matter for investors and the company’s future.